Evidence map›Paper›PMID 25320598›Full record

ArticleAfrican health sciences2014

Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.

David K Tumusiime, Emmanuel Musabeyezu, Eugene Mutimurah, Donald R Hoover, Qiuhu Shi, Emmanuel Rudakemwa, Victorien Ndacyayisenga, Jean Claude Dusingize, Jean D'Amour Sinayobye, Aimee Stewart and 2 more

Open access · hybridAbstract read
In one paragraph

Article in African health sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

David K TumusiimeUniversity of the Witwatersrand, Johannesburg and Kigali Health Institute, Kigali, Rwanda; dtumusime@khi.ac.rw.
Emmanuel MusabeyezuKing Faisal Hospital Kigali (KFH, K) Kigali Rwanda; emusabeyezu@gmail.com.
Eugene MutimurahRegional Alliance for Sustainable Development (RASD), Kigali Rwanda, eugene.mutimura@gmail.com.
Donald R HooverThe State University of New Jersey, New Brunswick, NJ USA drhoover@stat.rutgers.edu.
Qiuhu ShiSchool of Health Sciences and Practice, New York Medical College, NY, USA, qshi@data2solutions.com.
Emmanuel RudakemwaKing Faisal Hospital, Kigali, Rwanda, erudakemwa@gmail.com.
Victorien NdacyayisengaCentre Hospitalier Universitaire de Kigali (CHUK), Rwanda, ndacyayisengav@gmail.com.
Jean Claude DusingizeRASD, Kigali Rwanda, dusingize@gmail.com.
Jean D'Amour SinayobyeDepartment of Physiotherapy, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand; aimee.stewart@wits.ac.za.
Aimee StewartDepartment of Physiotherapy, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand; aimee.stewart@wits.ac.za.
Francois W D VenterDeputy Executive Director, Witwatersrand Reproductive Health and HIV Institute (WRHI), Associate Professor, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa, fventer@wrhi.ac.za.
Kathryn AnastosAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY USA, kathryn.anastos@gmail.com.
University of the Witwatersrand · ZACentre Hospitalier Universitaire de Kigali · RWRegional Alliance for Sustainable Development · RWAlbert Einstein College of Medicine · USNew York Medical College · USRutgers, The State University of New Jersey · USUniversity of Kigali · RW

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
INTERNATIONAL TRAINING IN AIDS/TB PREVENTION RESEARCHD43TW001403 · FIC · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 2000 to 2011
$3.8M
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASER01DK054615 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MULLIGAN, KATHLEEN · 1998 to 2002
$1.0M
FIC NIH HHS D43 TW001403FIC NIH HHS D43-TW001403NCATS NIH HHS UL1 TR001073NIAID NIH HHS AI-51519NIAID NIH HHS P30 AI051519NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI096299NIAID NIH HHS U01-AI-34993NIAID NIH HHS UO1-AI-35004NIDDK NIH HHS DK54615NIDDK NIH HHS R01 DK054615
6 · The paper itself

Abstract

backgroundPeripheral neuropathy symptoms (PNS) are commonly manifested in HIV-infected (HIV+) individuals, although data are limited on the prevalence and predictors of PNS in HIV+ patients from sub-Saharan Africa.

objectiveTo determine the prevalence and predictors of PNS in HIV+ and HIV-uninfected (HIV-) Rwandan women.

methodsData were analysed from 936 (710 HIV+ and 226 HIV-) women from the Rwanda Women Interassociation Study and Assessment (RWISA), an observational prospective cohort study investigating the effectiveness and toxicity of ART in HIV+ women.

resultsOf 936 enrolled, 920 (98.3%) were included in this analysis with 44% of HIV- and 52% of the HIV+ women reporting PNS (p=0.06). CD4+ count was not associated with PNS, although there was a non-significant trend towards higher prevalence in those with lower CD4+ counts. For the HIV- women, only alcohol and co-trimoxazole use were independently associated with PNS. WHO HIV stage IV illness and albumin ≤ 3.5 were associated with PNS in HIV+ women.

conclusionsThe rate of peripheral neuropathy symptoms reported in this cohort of HIV-infected African women seems implausible, and rather suggests that the screening tool for peripheral neuropathy in culturally diverse African settings be locally validated.

Indexed as

HIV SeronegativityAdultAgedCD4 Lymphocyte CountFemaleHealth Services Needs and DemandHIV-1HIV InfectionsHumansLogistic ModelsMiddle AgedPeripheral Nervous System DiseasesPrevalenceProspective StudiesRisk FactorsRwandaHIV and Rwandan womenPeripheral neuropathy symptoms

Identifiers

PMID25320598
PMCPMC4196398
OpenAlexW2140885854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.